Practice Test- Chemo Certification
Totect - ANS - Anecdote for Doxorubicin
\Warm Compress - ANS - Plant alkaloids and etoposide
\Bleomycin - ANS - bad for the lungs
\Leucovorin - ANS - potentiates the effects of 5-FU and decreases the effect of MTX
\Calvert Formula Components - ANS - Area under the curve (AUC)
Carboplatin
Creatinine Clearance
\Aromatase Inhibitors - ANS - used for postmenopausal women- osteoporosis
\Vesicant Administration - ANS - Prior to non-vesicant drugs
Through a central line or small gauge peripheral line
+ blood return
\Cytarabine - ANS - Assess gross motor movement and coordination
\Capillary Leak Syndrome S/S - ANS - HYPOtension and decreased UOP
\Most feared symptom of cancer - ANS - nausea/vomiting
\For CD20+ NHL - ANS - Rituximab
\S/E Anti-angiogenesis agents - ANS - bleeding events
delayed wound healing
thrombotic events
\Asparaginase - ANS - Test dose is given prior
\Hypersensitivity Drugs - ANS - Rituxan
Trastuzumab
Paclitacel
Cabazitaxel
\Cytostatic Agents - ANS - slow the growth of cancer cell
\Cytotoxic Agents - ANS - kill cancer cells
\Bone Pain - ANS - Common side effect of colony stimulating
\Cisplatin - ANS - Can cause ototoxicity and renal toxicity
\Alcohol - ANS - Solvent used in Carmustine
\Mesna - ANS - Used to prevent hemorrhagic cystitis
\Hypomagnesaemia - ANS - common side effect of arsenic trioxide (Trisenox)
\Vincristine - ANS - Neurologic Toxicity
-constipation
-cranial nerve dysfunction
-peripheral neuropathy
\Diarrhea - ANS - associated with
- 5-FU
-Idarubicin
-Ironetecan
\Provenge - ANS - Cancer treatment vaccine
\Temazolamide - ANS - crosses the blood brain barrier
Totect - ANS - Anecdote for Doxorubicin
\Warm Compress - ANS - Plant alkaloids and etoposide
\Bleomycin - ANS - bad for the lungs
\Leucovorin - ANS - potentiates the effects of 5-FU and decreases the effect of MTX
\Calvert Formula Components - ANS - Area under the curve (AUC)
Carboplatin
Creatinine Clearance
\Aromatase Inhibitors - ANS - used for postmenopausal women- osteoporosis
\Vesicant Administration - ANS - Prior to non-vesicant drugs
Through a central line or small gauge peripheral line
+ blood return
\Cytarabine - ANS - Assess gross motor movement and coordination
\Capillary Leak Syndrome S/S - ANS - HYPOtension and decreased UOP
\Most feared symptom of cancer - ANS - nausea/vomiting
\For CD20+ NHL - ANS - Rituximab
\S/E Anti-angiogenesis agents - ANS - bleeding events
delayed wound healing
thrombotic events
\Asparaginase - ANS - Test dose is given prior
\Hypersensitivity Drugs - ANS - Rituxan
Trastuzumab
Paclitacel
Cabazitaxel
\Cytostatic Agents - ANS - slow the growth of cancer cell
\Cytotoxic Agents - ANS - kill cancer cells
\Bone Pain - ANS - Common side effect of colony stimulating
\Cisplatin - ANS - Can cause ototoxicity and renal toxicity
\Alcohol - ANS - Solvent used in Carmustine
\Mesna - ANS - Used to prevent hemorrhagic cystitis
\Hypomagnesaemia - ANS - common side effect of arsenic trioxide (Trisenox)
\Vincristine - ANS - Neurologic Toxicity
-constipation
-cranial nerve dysfunction
-peripheral neuropathy
\Diarrhea - ANS - associated with
- 5-FU
-Idarubicin
-Ironetecan
\Provenge - ANS - Cancer treatment vaccine
\Temazolamide - ANS - crosses the blood brain barrier
